NervGen Pharma Corp. (NGEN)
2.00
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 09:40
NervGen Pharma Total Liabilities (Quarterly) : 51.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.39M |
| March 31, 2026 | 10.91M |
| December 31, 2025 | 14.40M |
| September 30, 2025 | 11.51M |
| June 30, 2025 | 13.08M |
| March 31, 2025 | 10.04M |
| December 31, 2024 | 11.76M |
| September 30, 2024 | 9.830M |
| June 30, 2024 | 11.25M |
| March 31, 2024 | 9.576M |
| December 31, 2023 | 11.56M |
| September 30, 2023 | 8.323M |
| June 30, 2023 | 7.448M |
| March 31, 2023 | 6.812M |
| December 31, 2022 | 7.686M |
| September 30, 2022 | 7.619M |
| June 30, 2022 | 2.409M |
| March 31, 2022 | 0.8962M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.8535M |
| September 30, 2021 | 0.8564M |
| June 30, 2021 | 0.8167M |
| March 31, 2021 | 0.9218M |
| December 31, 2020 | 0.5927M |
| September 30, 2020 | 0.2422M |
| June 30, 2020 | 0.402M |
| March 31, 2020 | 0.5112M |
| December 31, 2019 | 0.7125M |
| September 30, 2019 | 0.4332M |
| June 30, 2019 | 0.2504M |
| March 31, 2019 | 0.3551M |
| December 31, 2018 | 0.4269M |
| September 30, 2018 | 0.3642M |
| June 30, 2018 | 0.2788M |
| March 31, 2018 | |
| December 31, 2017 | 0.0759M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
| Clearmind Medicine, Inc. | 3.033M |
| Lexaria Bioscience Corp. | 0.4371M |
| Target Group, Inc. (Canada) | 14.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.57M |
| Shareholders Equity (Quarterly) | 12.18M |
| Current Ratio | 1.232 |
| Net Debt Paydown Yield | 0.01% |